脂肪性-话题@MedSci

#脂肪性#

235篇内容 | 4196人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1810204, encodeId=bef218102048a, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AJG：与乙型肝炎相比非酒精性脂肪性肝炎导致的肝硬化预后较差, objectType=article, longId=214334, objectId=a50d2143348a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a50d2143348a, replyNumber=0, likeNumber=80, createdTime=2021-12-31, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a50d2143348a, moduleTitle=AJG：与乙型肝炎相比非酒精性脂肪性肝炎导致的肝硬化预后较差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a50d2143348a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810207, encodeId=99a2181020ed6, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=课程回放：临床病例详解：代谢相关脂肪性肝病并发症, objectType=article, longId=215193, objectId=e6572151930b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6572151930b, replyNumber=0, likeNumber=72, createdTime=2022-03-02, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6572151930b, moduleTitle=课程回放：临床病例详解：代谢相关脂肪性肝病并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6572151930b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810209, encodeId=e86c181020922, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=无症状的代谢相关脂肪性肝病是否需要治疗？, objectType=article, longId=215502, objectId=67c421550283, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67c421550283, replyNumber=0, likeNumber=75, createdTime=2021-12-22, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67c421550283, moduleTitle=无症状的代谢相关脂肪性肝病是否需要治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67c421550283)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810198, encodeId=7650181019876, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=JAHA：伴有非酒精性脂肪性肝炎的肥胖患者心脏形态、功能和血流动力学改变, objectType=article, longId=209940, objectId=9601209940b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9601209940b7, replyNumber=0, likeNumber=0, createdTime=2022-02-17, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9601209940b7, moduleTitle=JAHA：伴有非酒精性脂肪性肝炎的肥胖患者心脏形态、功能和血流动力学改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9601209940b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810187, encodeId=72b1181018ec2, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=JCEM：青少年非酒精性脂肪性肝病与成年后的2型糖尿病风险, objectType=article, longId=202372, objectId=a30a2023e2b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a30a2023e2b6, replyNumber=0, likeNumber=112, createdTime=2021-03-26, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a30a2023e2b6, moduleTitle=JCEM：青少年非酒精性脂肪性肝病与成年后的2型糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a30a2023e2b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810192, encodeId=87151810192bd, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=NEJM：GLP-1受体激动剂治疗非酒精性脂肪性肝炎（NASH）：脂肪变性和肝损伤显著减轻，但纤维化改善不明显, objectType=article, longId=203520, objectId=4ff9203520a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ff9203520a1, replyNumber=0, likeNumber=72, createdTime=2020-12-29, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ff9203520a1, moduleTitle=NEJM：GLP-1受体激动剂治疗非酒精性脂肪性肝炎（NASH）：脂肪变性和肝损伤显著减轻，但纤维化改善不明显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ff9203520a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810193, encodeId=d058181019363, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Am J Gastroenterol：异体粪便微生物移植可改善非酒精性脂肪性肝病患者异常的小肠通透性, objectType=article, longId=204311, objectId=e78920431155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e78920431155, replyNumber=0, likeNumber=100, createdTime=2021-04-21, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e78920431155, moduleTitle=Am J Gastroenterol：异体粪便微生物移植可改善非酒精性脂肪性肝病患者异常的小肠通透性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e78920431155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810197, encodeId=469e181019e9e, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效, objectType=article, longId=208994, objectId=4de32089940d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4de32089940d, replyNumber=0, likeNumber=107, createdTime=2022-02-13, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4de32089940d, moduleTitle=NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4de32089940d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810188, encodeId=25de181018862, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果, objectType=article, longId=202786, objectId=6396202e8684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6396202e8684, replyNumber=0, likeNumber=77, createdTime=2021-08-25, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6396202e8684, moduleTitle=Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6396202e8684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810184, encodeId=cfd118101844e, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=JCEM：1型糖尿病患者非酒精性脂肪性肝病患病率, objectType=article, longId=199887, objectId=e8b519988efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8b519988efe, replyNumber=0, likeNumber=79, createdTime=2021-01-09, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8b519988efe, moduleTitle=JCEM：1型糖尿病患者非酒精性脂肪性肝病患病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8b519988efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810191, encodeId=e77e1810191de, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎新药FGF21-Fc融合蛋白Efruxifermin：2期临床进一步证明其强大的降脂降纤维化疗效, objectType=article, longId=203466, objectId=48e120346625, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48e120346625, replyNumber=0, likeNumber=94, createdTime=2021-10-26, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48e120346625, moduleTitle=非酒精性脂肪性肝炎新药FGF21-Fc融合蛋白Efruxifermin：2期临床进一步证明其强大的降脂降纤维化疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48e120346625)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810196, encodeId=37511810196ba, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Gut：非酒精性脂肪性肝病患者的胃肠道癌症风险增加高达2倍！, objectType=article, longId=208278, objectId=665b2082e84a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=665b2082e84a, replyNumber=0, likeNumber=83, createdTime=2021-05-17, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=665b2082e84a, moduleTitle=Gut：非酒精性脂肪性肝病患者的胃肠道癌症风险增加高达2倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=665b2082e84a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810177, encodeId=b09918101e7b4, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎新药HM15211，获得FDA快速通道指定, objectType=article, longId=197673, objectId=890919e6737a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=890919e6737a, replyNumber=0, likeNumber=80, createdTime=2020-09-18, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=890919e6737a, moduleTitle=非酒精性脂肪性肝炎新药HM15211，获得FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=890919e6737a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810172, encodeId=20be18101e2dd, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=诺和诺德的GLP-1激动剂semaglutide：非酒精性脂肪性肝炎的II期临床展现治疗潜力, objectType=article, longId=193810, objectId=97c7193810df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c7193810df, replyNumber=0, likeNumber=85, createdTime=2020-06-21, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c7193810df, moduleTitle=诺和诺德的GLP-1激动剂semaglutide：非酒精性脂肪性肝炎的II期临床展现治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97c7193810df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810180, encodeId=dbed1810180e0, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=双重PPAR激动剂治疗非酒精性脂肪性肝炎：III期临床宣布失败, objectType=article, longId=197999, objectId=2c2219e999bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c2219e999bb, replyNumber=0, likeNumber=70, createdTime=2020-12-05, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c2219e999bb, moduleTitle=双重PPAR激动剂治疗非酒精性脂肪性肝炎：III期临床宣布失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c2219e999bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810194, encodeId=fca1181019474, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Nat Commun：双阴性T细胞抑制非酒精性脂肪性肝炎的发生发展, objectType=article, longId=206921, objectId=cf67206921e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf67206921e3, replyNumber=0, likeNumber=88, createdTime=2021-04-28, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf67206921e3, moduleTitle=Nat Commun：双阴性T细胞抑制非酒精性脂肪性肝炎的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf67206921e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810171, encodeId=36de18101e151, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Gastroenterology：合生元可改变非酒精性脂肪性肝病患者的粪便微生物群但不改变肝脏脂肪或纤维化 , objectType=article, longId=193492, objectId=d99219349250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d99219349250, replyNumber=0, likeNumber=81, createdTime=2020-10-11, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d99219349250, moduleTitle=Gastroenterology：合生元可改变非酒精性脂肪性肝病患者的粪便微生物群但不改变肝脏脂肪或纤维化 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d99219349250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810174, encodeId=d15d18101e4a2, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）迎来新进展：lanifibranor达到期中研究的主要终点, objectType=article, longId=196006, objectId=cc5f1960069e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc5f1960069e, replyNumber=0, likeNumber=69, createdTime=2021-01-26, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc5f1960069e, moduleTitle=非酒精性脂肪性肝炎（NASH）迎来新进展：lanifibranor达到期中研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc5f1960069e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810176, encodeId=941a18101e6b0, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）新药Namodenoson：所有功效指标均得到显着且持续改善, objectType=article, longId=196884, objectId=c1dc196884ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1dc196884ba, replyNumber=0, likeNumber=82, createdTime=2021-04-04, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1dc196884ba, moduleTitle=非酒精性脂肪性肝炎（NASH）新药Namodenoson：所有功效指标均得到显着且持续改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1dc196884ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810181, encodeId=2ebe181018196, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）, objectType=article, longId=198731, objectId=37c9198e311c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37c9198e311c, replyNumber=0, likeNumber=94, createdTime=2020-11-18, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c9198e311c, moduleTitle=RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37c9198e311c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

脂肪性

2020-05-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

AJG：与乙型肝炎相比非酒精性脂肪性肝炎导致的肝硬化预后较差

2021-12-31

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

课程回放：临床病例详解：代谢相关脂肪性肝病并发症

2022-03-02

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

无症状的代谢相关脂肪性肝病是否需要治疗？

2021-12-22

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

JAHA：伴有非酒精性脂肪性肝炎的肥胖患者心脏形态、功能和血流动力学改变

2022-02-17

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

JCEM：青少年非酒精性脂肪性肝病与成年后的2型糖尿病风险

2021-03-26

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

NEJM：GLP-1受体激动剂治疗非酒精性脂肪性肝炎（NASH）：脂肪变性和肝损伤显著减轻，但纤维化改善不明显

2020-12-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Am J Gastroenterol：异体粪便微生物移植可改善非酒精性脂肪性肝病患者异常的小肠通透性

2021-04-21

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效

2022-02-13

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果

2021-08-25

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

JCEM：1型糖尿病患者非酒精性脂肪性肝病患病率

2021-01-09

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎新药FGF21-Fc融合蛋白Efruxifermin：2期临床进一步证明其强大的降脂降纤维化疗效

2021-10-26

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Gut：非酒精性脂肪性肝病患者的胃肠道癌症风险增加高达2倍！

2021-05-17

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎新药HM15211，获得FDA快速通道指定

2020-09-18

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

诺和诺德的GLP-1激动剂semaglutide：非酒精性脂肪性肝炎的II期临床展现治疗潜力

2020-06-21

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

双重PPAR激动剂治疗非酒精性脂肪性肝炎：III期临床宣布失败

2020-12-05

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Nat Commun：双阴性T细胞抑制非酒精性脂肪性肝炎的发生发展

2021-04-28

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Gastroenterology：合生元可改变非酒精性脂肪性肝病患者的粪便微生物群但不改变肝脏脂肪或纤维化

2020-10-11

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎（NASH）迎来新进展：lanifibranor达到期中研究的主要终点

2021-01-26

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎（NASH）新药Namodenoson：所有功效指标均得到显着且持续改善

2021-04-04

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）

2020-11-18

科室
- - 订阅+
  - 更多科室
工具
服务